Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial

dc.contributor.authorÖzakbaş, Serkan
dc.contributor.authorTürkoğlu, Recai
dc.contributor.authorTamam, Yusuf
dc.contributor.authorTerzi, Murat
dc.contributor.authorYücesan, Canan
dc.contributor.authorLimoncu Baser, Hatice
dc.contributor.authorGencer, Mehmet
dc.contributor.authorAkıl, Eşref
dc.contributor.authorSen, Sedat
dc.contributor.authorYiğit, Pınar
dc.contributor.buuauthorTaşkapılıoğlu, Özlem
dc.contributor.buuauthorTuran, Ömer Faruk
dc.contributor.buuauthorTürkeş, Nevin
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Nöroloji Beyin ve Sinir Hastalıkları Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0003-4436-3797tr_TR
dc.contributor.researcheridAAK-6623-2020
dc.contributor.researcheridJDI-6091-2023
dc.contributor.researcheridEAD-0629-2022
dc.contributor.scopusid23037226400tr_TR
dc.contributor.scopusid23037113500tr_TR
dc.contributor.scopusid35886020700tr_TR
dc.date.accessioned2024-01-26T06:23:24Z
dc.date.available2024-01-26T06:23:24Z
dc.date.issued2018-05
dc.description.abstractBackground: Cognitive impairment (CI) is a common problem in multiple sclerosis (MS), may occur either in early or late phase of the disease, and impairs quality of life. Objectives: This study aimed to determine the prevalence of CI and related risk factors in relapsing-remitting MS (RRMS) patients in Turkey. Methods: The present cross-sectional, multi-center, and nationally representative study included RRMS patients. Sociodemographic characteristics, cognitive functions and additional outcomes were compared between patients with and without CI. Results: The analyses included 487 RRMS patients. According to the BRB-N battery results, CI prevalence was 53.7%. There was a negative significant correlation of BRB-N subtests with age, disease duration, and EDSS and MSNQ-patient rated scores. On the logistic regression analysis, increased age, living in village/rural area, high income level, and high EDSS score were significant increasing risk factors in the development of CI. Conclusions: This is the first national cognitive data obtained from MS in Turkey, which is a country between Europe and Asia and thus has characteristics of both continents. The similarity of the results of the present study obtained from Turkey to the Western-based data indicates that CI is universal in MS and the main factors affecting CI have not changed.en_US
dc.description.sponsorshipMS Research Associationen_US
dc.identifier.citationÖzakbaş, S. vd. (2018). ''Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial''. Multiple Sclerosis and Related Disorders, 22, 70-76.en_US
dc.identifier.doihttps://doi.org/10.1016/j.msard.2018.03.009
dc.identifier.endpage76tr_TR
dc.identifier.issn2211-0348
dc.identifier.issn2211-0356
dc.identifier.pubmed29605801tr_TR
dc.identifier.scopus2-s2.0-85044620700tr_TR
dc.identifier.startpage70tr_TR
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S2211034818300968
dc.identifier.urihttps://hdl.handle.net/11452/39333
dc.identifier.volume22tr_TR
dc.identifier.wos000433294800016tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.indexed.wosSSCIen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalMultiple Sclerosis and Related Disordersen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNeurosciences & neurologyen_US
dc.subjectMultiple sclerosisen_US
dc.subjectCognitionen_US
dc.subjectPrognosisen_US
dc.subjectPrevalenceen_US
dc.subjectBrief repeatable batteryen_US
dc.subjectQyality-of-lifeen_US
dc.subjectFollow-upen_US
dc.subjectDysfunctionen_US
dc.subjectPopulationen_US
dc.subjectDepressionen_US
dc.subjectDisabilityen_US
dc.subjectMSen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAgeen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeCognitionen_US
dc.subject.emtreeCognitive defecten_US
dc.subject.emtreeCognitive function testen_US
dc.subject.emtreeComparative studyen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeCross-sectional studyen_US
dc.subject.emtreeDemographyen_US
dc.subject.emtreeDisease associationen_US
dc.subject.emtreeDisease durationen_US
dc.subject.emtreeDisease predispositionen_US
dc.subject.emtreeExpanded disability status scaleen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeHighest income groupen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMulticenter studyen_US
dc.subject.emtreeMultiple sclerosisen_US
dc.subject.emtreeMultiple sclerosis neuropsychological questionnaireen_US
dc.subject.emtreePrevalenceen_US
dc.subject.emtreeRisk factoren_US
dc.subject.emtreeRural populationen_US
dc.subject.emtreeSocial statusen_US
dc.subject.emtreeTurkey (republic)en_US
dc.subject.emtreeClinical trialen_US
dc.subject.emtreeCognitive defecten_US
dc.subject.emtreeComplicationen_US
dc.subject.emtreeDisabilityen_US
dc.subject.emtreeEducational statusen_US
dc.subject.emtreeMultiple sclerosisen_US
dc.subject.emtreeNeuropsychological testen_US
dc.subject.emtreePrevalenceen_US
dc.subject.emtreePsychologyen_US
dc.subject.emtreeRisk factoren_US
dc.subject.emtreeTime factoren_US
dc.subject.emtreeTurkey (bird)en_US
dc.subject.meshAdulten_US
dc.subject.meshAge factorsen_US
dc.subject.meshCognitive dysfunctionen_US
dc.subject.meshCross-sectional studiesen_US
dc.subject.meshDisability evaluationen_US
dc.subject.meshEducational statusen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMultiple sclerosis, relapsing-remittingen_US
dc.subject.meshNeuropsychological testsen_US
dc.subject.meshPrevalenceen_US
dc.subject.meshRisk factorsen_US
dc.subject.meshTime factorsen_US
dc.subject.meshTurkeyen_US
dc.subject.scopusMultiple Sclerosis; Neuropsychological Tests; Cognitionen_US
dc.subject.wosClinical neurologyen_US
dc.titlePrevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trialen_US
dc.typeArticleen_US
dc.wos.quartileQ2en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: